MedPath

Merck (Schweiz) AG

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Cetrorelix Acetate Powder for Injection

Product Name
思则凯
Approval Number
国药准字HJ20140476
Approval Date
Mar 1, 2024
NMPA

Tepotinib Hydrochloride Tablets

Product Name
拓得康
Approval Number
国药准字HJ20230132
Approval Date
Dec 5, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.